Paracetamol/Ibuprofen Viatris (Ibuprofen, Paracetamol)

Ibuprofen, the active ingredient in Paracetamol/Ibuprofen Viatris, is a non‑opioid analgesic combination presented as a tablet for oral use. It treats pain and fever in adults and children when both ibuprofen and paracetamol are indicated. GNH USA supplies Paracetamol/Ibuprofen Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Paracetamol/Ibuprofen Viatris is provided by GNH USA, a GMP‑certified manufacturer that distributes a broad portfolio of essential medicines to health‑care providers across global markets.

Paracetamol/Ibuprofen Viatris combines ibuprofen and paracetamol to address pain and inflammation pathways in several common conditions.

- Headache: provides rapid relief of mild to moderate headache pain. - Dental pain: reduces postoperative dental discomfort and swelling. - Musculoskeletal pain: alleviates pain and inflammation associated with sprains, strains and minor injuries. - Fever: lowers elevated body temperature in febrile adults and children. - Menstrual cramps: eases dysmenorrhea‑related pelvic pain. - Osteoarthritis (mild): helps manage intermittent joint pain in early‑stage osteoarthritis.

Paracetamol/Ibuprofen Viatris may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild stomach upset that often resolves without treatment. - Dyspepsia: occasional indigestion or heartburn. - Headache: transient headache may occur despite analgesic intent. - Dizziness: brief episodes of light‑headedness. - Rash: mild skin redness or itching. - Elevated liver enzymes: mild, asymptomatic increase detected on routine labs.

Serious or Rare Side Effects: - Gastrointestinal bleeding: ulceration or bleeding in the stomach or intestines. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatotoxicity: significant liver injury, especially with overdose. - Renal impairment: reduced kidney function or acute kidney injury. - Anaphylaxis: rare, potentially life‑threatening allergic reaction. - Cardiovascular events: increased risk of heart attack or stroke with prolonged high‑dose use.

When prescribing Paracetamol/Ibuprofen Viatris, clinicians should consider several safety aspects.

- Assess renal function: adjust use in patients with impaired kidney function. - Monitor liver enzymes: avoid in patients with active liver disease or chronic alcohol use. - Avoid in third‑trimester pregnancy: risk of fetal complications. - Use caution in asthma: ibuprofen may trigger bronchospasm in susceptible individuals. - Review concomitant NSAID or acetaminophen use: limit total daily dose to prevent toxicity. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Paracetamol/Ibuprofen Viatris can interact with several medicines, requiring attention to dosage and monitoring.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - High‑dose aspirin: heightened gastrointestinal toxicity. - Lithium: ibuprofen may raise serum lithium levels, risking toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal perfusion, especially in volume‑depleted patients. - Diuretics: combined effect can impair kidney function. - Selective serotonin reuptake inhibitors (SSRIs): modest increase in bleeding risk. - Methotrexate: ibuprofen can decrease clearance, raising toxicity potential.